Oculis Holding AG (OCS) Other Operating Expenses (2022 - 2026)
Oculis Holding AG (OCS) recorded quarterly Other Operating Expenses of -$196658.7 in Q1 2026, up 0.52% quarter-over-quarter from -$197684.8 in Q4 2025, and down 43.75% on a YoY basis from -$349610.6 in Q1 2025.
Oculis Holding AG (OCS) Other Operating Expenses (2022 - 2026) Analysis & Trends
Oculis Holding AG's Other Operating Expenses history runs 5 years deep, the most recent figure standing at -$196658.7 for Q1 2026.
- In Q1 2026, Other Operating Expenses fell 43.75% year-over-year to -$196658.7; the TTM figure through Mar 2026 stood at -$720851.8 (down 39.89% YoY), while the FY2025 annual figure was -$683138.7, down 47.4% from the prior year.
- Other Operating Expenses was -$196658.7 for Q1 2026 at Oculis Holding AG, up from -$197684.8 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of -$0.0 in Q3 2022 to a low of -$37.7 million in Q1 2023.
- Historically, Other Operating Expenses has averaged -$2.8 million across 5 years, with a median of -$136649.2 in 2025.
- The sharpest annual moves came in 2023 and 2024: Other Operating Expenses sank 8874168778730300.0% in 2023, then soared 99.78% in 2024.
- A 5-year view of Other Operating Expenses shows it stood at -$0.0 in 2022, then sank by 4478804300991900.0% to -$83424.2 in 2023, then sank by 66.94% to -$139265.7 in 2024, then plunged by 41.95% to -$197684.8 in 2025, then increased by 0.52% to -$196658.7 in 2026.
- The last three Other Operating Expenses figures came in at -$196658.7 (Q1 2026), -$197684.8 (Q4 2025), and -$190016.6 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Oculis Holding AG | 8.23 Bn | 7.92 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -196,658.72 |
| Dec 31, 2025 | -197,684.83 |
| Sep 30, 2025 | -190,016.65 |
| Jun 30, 2025 | -136,491.60 |
| Mar 31, 2025 | -136,806.82 |
| Dec 31, 2024 | -139,265.67 |
| Sep 30, 2024 | -140,813.28 |
| Jun 30, 2024 | -98,415.62 |
| Mar 31, 2024 | -83,634.81 |
| Dec 31, 2023 | -83,424.23 |
| Sep 30, 2023 | -82,647.14 |
| Mar 31, 2023 | -37.69 Mn |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.00 |